Live Breaking News & Updates on Michaels Garshick

Stay updated with breaking news from Michaels garshick. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Lp(a), LDL management, health system quality metrics and more in spotlight at NLA 2024

The National Lipid Association Scientific Sessions will be held Thursday to Sunday and will spotlight emerging areas of research such as “cardio-rheumatology,” a renewed push to reinstate LDL as a health system quality metric and more. Christie M. Ballantyne, MD, FACC, FACP, FAHA, FNLA, chief of the section of cardiovascular research and professor of medicine at Baylor College of ....

United States , Las Vegas , Vijay Nambi , Joel Gelfand , Michaels Garshick , Daniele Soffer , Silva Arslanian , Christiem Ballantyne , Alans Brown , Payal Kohli , Ann Liebeskind , Laurena Eberly , Anandita Agarwala Kulkarni , Byscott Buzby , Jamesa Underberg , Mary Katherine Cheeley , W Virgil Brown , Chrisandra Shufelt , Jennifer Lewey , Richard Smith , Roberta Hegele , Danielj Rader , Baylor College Of Medicine , Health System , National Lipid Association Scientific Sessions , European Atherosclerosis Association ,

In RA Treatment, Don't Overlook Underlying CV Risks

Disease-modifying antirheumatic drugs can reduce some cardiovascular risk in patients with rheumatoid arthritis, but questions remain if that's enough when statin use lags. ....

Michaels Garshick , Los Angeles , Jont Giles , Langone Health , Sinai Inflammatory Arthritis Clinical Center At Cedars , Annual Cardiometabolic Risk , Inflammatory Conditions , Modifying Antirheumatic Drugs ,

Reducing CVD Morbidity and Mortality in Psoriasis and PsA

Only a minority of patients with psoriatic disease know about their increased risks. ....

United States , Joelm Gelfand , Johns Barbieri , Alexisr Ogdie Beatty , Michaels Garshick , Joel Gelfand , York University Langone Health , National Ambulatory Medical Care , National Psoriasis Foundation , American Academy Of Dermatology , Langone Health , American Academy , New York University Langone Health , National Ambulatory Medical Care Survey , Advanced Acne Therapeutics Clinic , Psoriatic Arthritis , Rthropathic Psoriasis , Psoriatic Arthropathy , Cv Risk , Cardiovascular Risk , V Risk Factors , Cardiovascular Risk Factors , Cardiovascular Risk Management , Prostate Specific Antigen , Sa Prostate Specific Antigen , Ipid Management ,

CV, VTE Risk Not Seen in Derm Studies of JAK Inhibitors

There remains a knowledge gap regarding the risk of JAK inhibitor use and VTE and/or MACE in the dermatologic population, the study authors wrote. ....

United States , Northwestern University , Raj Chovatiya , Michaels Garshick , Bristol Myers Squibb , York University Langone Health , Kiniksa Pharmaceuticals , New York University Langone Health , Preferred Reporting Items , Systematic Reviews , Oint Inflammation , Psoriatic Arthritis , Rheumatoid Arthritis , Skin Disorders , Skin Diseases , Meta Analysis , Atopic Dermatitis , Alopecia Areata , Alignant Neoplasia , Clinical Guidelines , Clinical Research , Clinical Trial ,

Elevated PCSK9-Psoriasis Link: A New Target for Treatment?

The study suggests that "PCSK9 inhibition is causally associated with reduced risk of psoriasis" and has implications for prevention and possibly treatment of psoriasis, the investigators say. ....

United States , United Kingdom , Chugai Roche , Sizheng Steven Zhao , Michaels Garshick , York University Langone Health , American Academy Of Dermatology , University Of Manchester England , National Psoriasis Foundation , Bristol Myers Squibb , Manchester Biomedical Research Centre , American Academy , National Psoriasis , New York University Langone , Versus Arthritis , National Institute , Biomedical Research , Ipid Management , Roprotein Convertase Subtilisin Kexin Type 9 , Clinical Research , Clinical Trials , Linical Studies , Oint Inflammation , Genomic Medicine , Edicine Genomic , Healthcare And Medical Technology ,